Skip to main content

. 1952 Oct;31(10):872–879. doi: 10.1172/JCI102674

CARDIOVASCULAR AND RENAL ADJUSTMENTS TO A HYPOTENSIVE AGENT

(l-HYDRAZINOPHTHALAZINE: CIBA BA-5968: APRESOLINE) ¹,²

Ernest L Wilkinson ^1,³, Heikki Backman ^1,³, Hans H Hecht ¹

PMCID: PMC436486 PMID: 12990658

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Bradley S. E., Chasis H., Goldring W., Smith H. W. HEMODYNAMIC ALTERATIONS IN NORMOTENSIVE AND HYPERTENSIVE SUBJECTS DURING THE PYROGENIC REACTION. J Clin Invest. 1945 Sep;24(5):749–758. doi: 10.1172/JCI101660. [DOI] [PMC free article] [PubMed] [Google Scholar]
CRAVER B. N., BARRETT W., CAMERON A., YONKMAN F. F. The activities of 1-hydrazinophthalazine (Ba-5968); a hypotensive agent. J Am Pharm Assoc Am Pharm Assoc. 1951 Nov;40(11):559–564. doi: 10.1002/jps.3030401109. [DOI] [PubMed] [Google Scholar]
Chasis H., Ranges H. A., Goldring W., Smith H. W. THE CONTROL OF RENAL BLOOD FLOW AND GLOMERULAR FILTRATION IN NORMAL MAN. J Clin Invest. 1938 Sep;17(5):683–697. doi: 10.1172/JCI100996. [DOI] [PMC free article] [PubMed] [Google Scholar]
FREIS E. D., FINNERTY F. A., Jr Suppression of vasomotor reflexes in man following L-hydrazinophthalozine (C-5968). Proc Soc Exp Biol Med. 1950 Oct;75(1):23–24. doi: 10.3181/00379727-75-18085. [DOI] [PubMed] [Google Scholar]
FREIS E. D., MacKAY J. C., OLIVER W. F. The effect of sympatholytic drugs on the cardiovascular responses to epinephrine and norepinephrine in man. Circulation. 1951 Feb;3(2):254–259. doi: 10.1161/01.cir.3.2.254. [DOI] [PubMed] [Google Scholar]
GROSS F., DRUEY J., MEIER R. Eine neue Gruppe blutdrucksenkender Substanzen von besonderem Wirkungscharakter. Experientia. 1950 Jan 15;6(1):19–21. doi: 10.1007/BF02154049. [DOI] [PubMed] [Google Scholar]
REUBI F. C. Renal hyperemia induced in man by a new phthalazine derivative. Proc Soc Exp Biol Med. 1950 Jan;73(1):102–102. doi: 10.3181/00379727-73-17591. [DOI] [PubMed] [Google Scholar]
Reubi F. C., Futcher P. H. THE EFFECTS OF HISTAMINE ON RENAL FUNCTION IN HYPERTENSIVE AND NORMOTENSIVE SUBJECTS. J Clin Invest. 1949 May;28(3):440–446. doi: 10.1172/JCI102088. [DOI] [PMC free article] [PubMed] [Google Scholar]
SCHMID A., REUBI F. Hämodynamische Eigenschaften zweier neuer Phthalazinderivate. Helv Med Acta. 1950 Oct;17(4-5):543–546. [PubMed] [Google Scholar]
SCHROEDER N. A. The effect of 1-hydrasinophthalasine in hypertension. Circulation. 1952 Jan;5(1):28–37. doi: 10.1161/01.cir.5.1.28. [DOI] [PubMed] [Google Scholar]
TAYLOR R. D., PAGE I. H., CORCORAN A. C. A hormonal neurogenic vasopressor mechanism. AMA Arch Intern Med. 1951 Jul;88(1):1–8. doi: 10.1001/archinte.1951.03810070011001. [DOI] [PubMed] [Google Scholar]
WALKER H. A., WILSON S., ATKINS E. C., GARRETT H. E., RICHARDSON A. P. The effect of 1-hydrazinophthalazine (C-5968) and related compounds on the cardiovascular system of dogs. J Pharmacol Exp Ther. 1951 Apr;101(4):368–378. [PubMed] [Google Scholar]
YONKMAN F. F. Neurogenic hypertension; chemical approaches to its amelioration. J Mich State Med Soc. 1951 Feb;50(2):160–167. [PubMed] [Google Scholar]

ACTIONS

RESOURCES